Convalescent plasma to prevent COVID-19 – UCLA Health Clinical Trials

Most convalescent plasma thus far has been to treat people with active and serious COVID-19 infections. This UCLA clinical trial focuses on the use of convalescent plasma in individuals exposed to a COVID-19 positive patient.

The goal of the study is to determine whether post-exposure treatment with convalescent plasma is effective in preventing these patients from getting COVID-19.

Generally with any treatment or preventative measure like using convalescent plasma or antibodies, earlier use is more effective.